Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin: 1-Year Follow-Up Study

Publisher： Karger

E-ISSN： 2235-3186|86|2|200-201

ISSN： 1660-8151

Source： Nephron, Vol.86, Iss.2, 2000-09, pp. : 200-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin

By  

Nephron, Vol. 80, Iss. 3, 1998-11 ,pp. : 369-370

Karger

Access to resources Recommend Favorite

Low Hip Bone Mineral Density Predicts Mortality in Maintenance Hemodialysis Patients: A Five-Year Follow-Up Study

By  

Blood Purification, Vol. 37, Iss. 1, 2014-02 ,pp. : 33-38

Karger

Access to resources Recommend Favorite

Oral Low-Dose Ferric Citrate Is a Useful Iron Source for Hyperphosphatemic Hemodialysis Patients: A Case Series

By  

Blood Purification, Vol. 43, Iss. 1-3, 2016-12 ,pp. : 97-100

Karger

Access to resources Recommend Favorite

Impact of Vascular Calcifications on Arteriovenous Fistula Survival in Hemodialysis Patients: A Five-Year Follow-Up

By  

Nephron, Vol. 129, Iss. 4, 2015-03 ,pp. : 247-252

Karger

Access to resources Recommend Favorite

Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up

By  

Blood Purification, Vol. 39, Iss. 4, 2015-04 ,pp. : 266-273

Karger

Access to resources Recommend Favorite